(S)-N-(((R)-5-(4-(dimethylamino)piperidin-1-yl)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-N-methyl-5,6,7,8-tetrahydroquinolin-8-amine

ID: ALA4876951

PubChem CID: 146398482

Max Phase: Preclinical

Molecular Formula: C27H39N5

Molecular Weight: 433.64

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)C1CCN(c2cccc3c2C[C@H](CN(C)[C@H]2CCCc4cccnc42)NC3)CC1

Standard InChI:  InChI=1S/C27H39N5/c1-30(2)23-12-15-32(16-13-23)25-10-5-8-21-18-29-22(17-24(21)25)19-31(3)26-11-4-7-20-9-6-14-28-27(20)26/h5-6,8-10,14,22-23,26,29H,4,7,11-13,15-19H2,1-3H3/t22-,26+/m1/s1

Standard InChI Key:  CRZQSSHPSOLJFR-GJZUVCINSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   17.4980  -12.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4969  -12.9824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2049  -13.3914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2031  -11.7540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9118  -12.1593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9106  -12.9845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6207  -13.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3365  -12.9865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3377  -12.1614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6230  -11.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6184  -14.2130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9095  -14.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9072  -15.4368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1973  -15.8413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1930  -16.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6143  -15.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6084  -16.6639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8977  -17.0674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8927  -17.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5977  -18.2956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3091  -17.8872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3106  -17.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0196  -16.6667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3249  -14.6236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7230  -17.0825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4297  -16.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4364  -15.8620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7300  -15.4491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0171  -15.8538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1468  -15.4582    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8518  -15.8715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1523  -14.6410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  6
 11 12  1  0
 13 12  1  1
 13 14  1  0
 13 16  1  0
 14 15  1  0
 15 18  1  0
 17 16  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 22 23  1  0
 11 24  1  0
 23 25  1  0
 23 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  1  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4876951

    ---

Associated Targets(Human)

CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.64Molecular Weight (Monoisotopic): 433.3205AlogP: 3.64#Rotatable Bonds: 5
Polar Surface Area: 34.64Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.83CX LogP: 3.51CX LogD: -0.29
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.78Np Likeness Score: -0.62

References

1. Nguyen HH, Tahirovic YA, Truax VM, Wilson RJ, Jecs E, Miller EJ, Kim MB, Akins NS, Xu L, Jiang Y, Wang T, Sum CS, Cvijic ME, Schroeder GM, Wilson LJ, Liotta DC..  (2021)  Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings.,  12  (10.0): [PMID:34676043] [10.1021/acsmedchemlett.1c00449]

Source